NTBLQ (Notable Labs) Payments of Debt : $-0.04 Mil (TTM As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Notable Labs Payments of Debt?

Notable Labs's Payments of Debt for the three months ended in Jun. 2024 was $-0.02 Mil.

Notable Labs's Payments of Debt for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.04 Mil.

Notable Labs Payments of Debt Historical Data

The historical data trend for Notable Labs's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs Payments of Debt Chart

Notable Labs Annual Data

Trend

Dec21

Dec22

Dec23

Payments of Debt

-0.06

Notable Labs Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Dec23	Mar24	Jun24
Payments of Debt	Get a 7-Day Free Trial			-0.01	-0.02	-	-0.02	-0.02

Notable Labs Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.04 Mil.

Notable Labs Payments of Debt Related Terms

Thank you for viewing the detailed overview of Notable Labs's Payments of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Notable Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (OTCPK:NTBLQ) » Definitions » Payments of Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

320 Hatch Drive, Foster City, CA, USA, 94404

Website

https://notablelabs.com

Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.